Financials

  • Market Capitalization 2.08 B
  • Employee 81
  • Founded 2004
  • CEO Silviu Itescu
  • Website www.mesoblast.com
  • Headquarter Australia
  • FIGI BBG000QD6LZ1
  • Industry Biotechnology
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1929
OCUL
Ocular Therapeutix, Inc. - Common Stock
9.88 USD-3.14%+0.82%+10.51%-14.09%2.16 B USD
1961
ADMA
ADMA Biologics Inc - Common Stock
8.97 USD-1.21%-3.34%+8.60%-51.93%2.08 B USD
1965
AUPH
Aurinia Pharmaceuticals Inc - Common Shares
16.03 USD+1.58%+3.42%+0.63%+34.37%2.06 B USD
1966
HRMY
Harmony Biosciences Holdings, Inc. - Common Stock
35.54 USD-3.53%-5.07%+3.95%+15.02%2.06 B USD

Frequently asked questions about Mesoblast Limited - American Depositary Shares

What is the Mesoblast Limited - American Depositary Shares stock price today?

The current price of Mesoblast Limited - American Depositary Shares (MESO) is 16.22. Over the past 24 hours, the stock has changed by +5.05%. Follow the MESO chart for real-time price dynamics.

What is the stock ticker of Mesoblast Limited - American Depositary Shares?

Mesoblast Limited - American Depositary Shares trades under the ticker MESO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Mesoblast Limited - American Depositary Shares stock going up?

MESO has changed by +12.64% over the last week, +16.77% over the last month, and +44.95% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does Mesoblast Limited - American Depositary Shares have?

As of the latest available data, Mesoblast Limited - American Depositary Shares has 81 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Mesoblast Limited - American Depositary Shares stock?

You can buy Mesoblast Limited - American Depositary Shares (MESO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Mesoblast Limited - American Depositary Shares stock?

Investing in Mesoblast Limited - American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MESO chart and related analysis on metatrader.com as part of your research.

Mesoblast Limited - American Depositary Shares

Mesoblast Limited is an Australian regenerative medicine company. It seeks to provide treatments for inflammatory ailments, cardiovascular disease, and back pain. The company is led by Silviu Itescu, who founded the company in 2004.

News